000			01745nam a2200301 a 4500
005			20250914123223.0
008			020606s2001 xxua 001 0 eng b
020			_a0824702948 _cRM602.40
039		9	_a200208140935 _bnormila _c200208011201 _dnormila _c200206240855 _dlinda _y06-06-2002 _zzaleha
060			_aQZ202
090			_aQZ202.G33156 2001 9HUKM
245	0	0	_aGenetic toxicology and cancer risk assessment / _cedited by Wai Nang Choy
260			_aNew York : _bMarcel Dekker, _c2001
300			_a390 p. : _bill. ; _c24 cm.
504			_aIncludes bibliographical references and index
505		0	_aHuman cancer genetics -- Genetic toxicity for predicting carcinogenicity -- Genotoxic and nongenotoxic mechanisms of carcinogenesis -- Structure-activity relationship (SAR) and its role in cancer risk assessment -- Regulatory genetic toxicology test -- Complementary genetic toxicology assays -- The mouse lymphoma assay (MLA) using the microwell method -- The in vivo micronucleus assay -- ICH guidances on genotoxicity and carcinogenicity : scientific background and regulatory practice -- New OECD genetic toxicity carcinogens -- Molecular epidemiology and biomarkers -- Quantitative cancer risk assessment of nongenotoxic carcinogens -- Risk assessment of genotoxic carcinogens -- Biologically based cancer risk assessment models
650		2	_aNeoplasms _xetiology
650		2	_aMutagenicity Tests _xmethods
650		2	_aRisk Assessment
700	1		_aChoy, Wai Nang
907			_a.b13018966 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kQZ202.G33156 2001 9HUKM
914			_avtls000314147
990			_amila
991			_aJabatan Onkologi, HUKM
998			_ah _b2002-06-06 _cm _da _feng _gxxu _y0 _z.b13018966
999			_c302110 _d302110